Central Nervous System Diseases - drug therapy.

The third histamine receptor = selective ligands as potential therapeutic agents in CNS disorders / by: (書目-語言資料,印刷品)

Animal and translational models for CNS drug discovery by: (書目-語言資料,印刷品)

Handbook of neuroemergency clinical trials by: (書目-語言資料,印刷品)

Handbook of neuroemergency clinical trials by: (書目-語言資料,印刷品)

Blood-brain barrier in drug discovery = optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs / by: (書目-語言資料,印刷品)

Neuropsychopharmacology and therapeutics by: (書目-語言資料,印刷品)

Nanotechnology methods for neurological diseases and brain tumors : = drug delivery across the blood--brain barrier / by: (書目-語言資料,印刷品)

Drug Discovery

Clinical trials

Mental Disorders

Central Nervous System Diseases

Drug Delivery Systems.

Emergency Medicine

Etudes cliniques

Histamine H3 Antagonists

Drug-Related Side Effects and Adverse Reactions

Animal models in research.

Therapeutics.

Histamine

Neuroprotective Agents

Systeme nerveux

Receptors, Histamine H3

Central Nervous System

Clinical Trials

Central Nervous System Agents

Nanotechnology.

Drug Discovery.

Nervous system

Blood-Brain Barrier

Drug development.

Blood-brain barrier

Disease Models, Animal.

Neuropharmacology

Nanomedicine

Central nervous system

Neuropharmacologie

Neuropsychopharmacology.

Antihistamines.